跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Amamcla - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Amamcla
Approved
STANDARD
Amamcla
Gnana Life Sciences Pvt. Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
c0556f08b915c1f5
Company
Gnana Life Sciences Pvt. Ltd.
Type
Standard
Approval Details
Approval Id
c0556f08b915c1f5
Drug Approval Philippines Name
Amamcla
Product Name
Amamcla
Registration Number
DRP-3620
Brand Name
Amamcla
Generic Name
Co-Amoxiclav
Dosage Form
Powder For Injection Iv
Dosage Strength
100 mg / 200 mg
Manufacturer
Gnana Life Sciences Pvt. Ltd.
Importer
Ambica International Corporation
Distributor
Ambica International Corporation
Issuance Date
27 October 2022
Expiry Date
18 February 2028
Pharmacologic Category
Antibacterial (Penicillin)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
c0556f08b915c1f5
Type
Standard
Back to Philippines FDA Approvals